Recombinant SARS-CoV-2 S RBD (XBB.1.5) Antigen, His
Cat No | BIOS-2076A |
Conjugate | |
Type | 重組蛋白 |
Source | N/A |
Tag | His |
Size | 100ug |
Application | Immunology |
Format | Liquid |
Purity | >95% |
Concentration | Please refer to the vial lable for the specific concentration. |
Buffer | Supplied in PBS; pH 7.4. |
Storage | Store at -20 degree for long term. |
Synonyms | SARS-CoV-2 RBD Protein;SARS-CoV-2 Spike RBD Protein;SARS-CoV-2 S Protein RBD |
Purification | SDS-PAGE |
MolecularWeight | |
Description | |
Background | The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
We can provide a variety of products such as diagnostic proteins; target proteins; cytokines; etc.